ADHD management app Inflow raised $11 million in a Series A round.
The London-based company has raised $14 million since it was founded in 2020, according to a news release. It will use the funds to expand its employee headcount and develop its products.
Inflow offers an app that helps users develop self-management skills. Its content is based on cognitive behavioral therapy (CBT). The company positions the app as an affordable and accessible option addressing ADHD symptoms.
Users can also access group and community support with other users led by Inflow coaches.
Founders Levi Epstein, Seb Isaacs and George Sachs, created the app in response to challenges in accessing behavioral health clinicians — specifically long wait times and bureaucratic hurdles.
“We want to help our members make significant improvements to their quality of life by giving them the tools to better understand themselves, and implement coping strategies that actually work,” Isaacs said in the release.
Companies seeking to treat ADHD via telehealth and medication management have seen scrutiny in recent years as concerns over loosened federal prescribing regulations led to a boom in membership growth. TruePill, a virtual pharmacy and partner to several telehealth companies, has seen the Drug Enforcement Administration move against its license over prescriptions it filled for controlled substances.
Inflow’s Series A round was led by Octopus Ventures, the multi-stage London-based venture capital firm. Existing investors Hoxton Ventures, London-based early-stage venture firm, and Alexandria, Virginia-based Route66 Ventures also participated, according to a news release.
Will Gibbs, the health tech partner at Octopus Ventures, joins the Inflow board.
Other investors in the co-founders of Quit Genius, including CEO Yusuf Sherwani, and the CEO of DoNotPay Joshua Browder.
A recent estimate places the prevalence rate of ADHD at 3.5% in the U.S.
Companies featured in this article:
